ECO ANIMAL HLTH GR.LS-05
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatm… Read more
ECO ANIMAL HLTH GR.LS-05 (LWA) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ECO ANIMAL HLTH GR.LS-05 (LWA) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ECO ANIMAL HLTH GR.LS-05 - Net Assets Trend (None–None)
This chart illustrates how ECO ANIMAL HLTH GR.LS-05's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ECO ANIMAL HLTH GR.LS-05 (None–None)
The table below shows the annual net assets of ECO ANIMAL HLTH GR.LS-05 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ECO ANIMAL HLTH GR.LS-05's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ECO ANIMAL HLTH GR.LS-05 Competitors by Market Cap
The table below lists competitors of ECO ANIMAL HLTH GR.LS-05 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GlycoNex
TWO:4168
|
$64.89 Million |
|
GRUPO ECOENER EO -32
F:89W
|
$64.90 Million |
|
Bertrandt AG
LSE:0NYZ
|
$64.92 Million |
|
ESTsoft Corp
KQ:047560
|
$64.92 Million |
|
Lundin Energy AB
PINK:LNDNF
|
$64.87 Million |
|
EuroHold Bulgaria AD
WAR:EHG
|
$64.86 Million |
|
MNULF
PINK:MNULF
|
$64.84 Million |
|
Kulmbacher Brauerei Aktien-Gesellschaft
MU:KUL
|
$64.84 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ECO ANIMAL HLTH GR.LS-05's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ECO ANIMAL HLTH GR.LS-05's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ECO ANIMAL HLTH GR.LS-05 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ECO ANIMAL HLTH GR.LS-05's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ECO ANIMAL HLTH GR.LS-05 (LWA) | €- | N/A | N/A | $64.88 Million |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |